down arrow

Voyageur Pharmaceuticals Ltd.

  • Market Cap: N/A
  • Industry: Chemicals & Petrochemicals
  • ISIN: CA92918C1014
CAD
0.15
-0.05 (-23.08%)

Dec 04

TSX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

0.060.36
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

CAD 24 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.34

stock-summary
Return on Equity

-175.81%

stock-summary
Price to Book

24.06

Revenue and Profits:
Net Sales:
(Quarterly Results - May 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
172.73%
0%
172.73%
1 Year
87.5%
0%
87.5%
2 Years
130.77%
0%
130.77%
3 Years
36.36%
0%
36.36%
4 Years
7.14%
0%
7.14%
5 Years
114.29%
0%
114.29%

Voyageur Pharmaceuticals Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-0.80
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.50
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
23.26
EV to EBIT
-13.49
EV to EBITDA
-13.50
EV to Capital Employed
22.92
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-169.93%
ROE (Latest)
-175.81%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended May 2025 is 0.00% vs 0.00% in May 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended May 2025 is 16.67% vs 0.00% in May 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "May'25",
        "May'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.50",
          "val2": "-0.60",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.50",
          "val2": "-0.60",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Nov'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Nov 2024 is 0.00% vs 0.00% in Nov 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Nov 2024 is -21.43% vs 22.22% in Nov 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'24",
        "Nov'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.70",
          "val2": "-1.30",
          "chgp": "-30.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.70",
          "val2": "-1.40",
          "chgp": "-21.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - May'25 - YoYstock-summary
May'25
May'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.50
-0.60
16.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.50
-0.60
16.67%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended May 2025 is 0.00% vs 0.00% in May 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended May 2025 is 16.67% vs 0.00% in May 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Nov'24stock-summary
Nov'24
Nov'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.70
-1.30
-30.77%
Interest
0.00
0.00
Exceptional Items
-0.00
-0.10
100.00%
Consolidate Net Profit
-1.70
-1.40
-21.43%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Nov 2024 is 0.00% vs 0.00% in Nov 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Nov 2024 is -21.43% vs 22.22% in Nov 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Voyageur Pharmaceuticals Ltd. stock-summary
stock-summary
Voyageur Pharmaceuticals Ltd.
Chemicals & Petrochemicals
Voyageur Pharmaceuticals Ltd., formerly Voyageur Minerals Ltd., is an exploration stage pharmaceutical company. The Company is focused on manufacturing mineral based pharmaceutical products. The Company is engaged in the acquisition, exploration and evaluation of pharmaceutical mineral resource properties. It has interests in five mineral properties located in the province of British Colombia, Canada and the state of Utah, United States of America.
Company Coordinates stock-summary
Company Details
Suite 255, 339 50th Avenue SE , CALGARY AB : T2G 2B3
stock-summary
Tel: 1 587 7796166
stock-summary
https://voyageurpharmaceuticals.ca/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."